Article
Breakingviews - Obesity revolution gorges on dialysis maker
Rating:
0.0
Views:
74
Likes:
1
Library:
1
Kidney dialysis kit-makers look set to be the latest victim of the obesity drug boom. On Wednesday, shares in Germany-listed Fresenius Medical Care fell 20% after a medical trial showed a Novo Nordisk drug can reduce the risk of kidney failure. With the prospect of lower earnings in the future, the company's parent, a 14 billion euro conglomerate also called Fresenius , may accelerate much-needed surgery.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value